CA9 and breast cancer: Interestingly, Lock et al. [28] demonstrated that the CA IX inhibitor U-104 (synonym of SLC-0111), depleting CSCs from breast cancer xenografts, enhanced the effect of paclitaxel in delaying tumor growth and reducing spontaneous metastasis in vivo.